基于多参数MRI的影像组学列线图用于术前预测乳腺浸润性导管癌患者淋巴血管侵犯及临床结局
本研究纳入160例病理确诊乳腺浸润性导管癌患者(训练集112例,验证集48例),基于T2WI、ADC图和增强T1WI提取影像组学特征构建融合标签及列线图,用于术前预测淋巴血管侵犯。列线图结合融合影像组学标签与MRI报告瘤周水肿,训练集和验证集AUC分别为0.919(95%CI 0.871-0.967)和0.863(95%CI 0.726-0.999);影像组学标签及列线图定义的高危组无病生存期较低危组缩短(均p<0.05)。
要点
- 融合T2WI、cT1WI和ADC图的影像组学标签对LVI的预测效能优于任一单独序列。
- 列线图结合融合影像组学标签与MRI报告的瘤周水肿,训练集AUC 0.919,验证集AUC 0.863。
- 影像组学标签及列线图定义的高危组DFS较低危组缩短(均p<0.05)。
核心结论
- 基于多参数MRI影像组学标签和MRI报告瘤周水肿的列线图,对IDC患者LVI及临床结局实现了满意的术前预测。
研究设计与样本
- 研究纳入160例病理确诊乳腺IDC患者(训练集112例,验证集48例),均行术前乳腺MRI,从T2WI、ADC图和cT1WI提取影像特征,采用四步法筛选特征并构建影像组学标签,经单因素和多因素logistic回归筛选LVI相关特征并纳入列线图。
关键影像表现/征象
- MRI报告的瘤周水肿被纳入列线图,与融合影像组学标签共同预测LVI。
- 融合T2WI、cT1WI和ADC图的影像组学标签对LVI的预测效能优于任一单独序列。
诊断标准与关键数值
- 列线图预测LVI的AUC在训练集为0.919(95%CI 0.871-0.967),在验证集为0.863(95%CI 0.726-0.999)。
- 影像组学标签和列线图定义的高危组DFS较低危组缩短(均p<0.05)。
- 在全队列中,较高的Rad-score与较差的DFS独立相关(p<0.05)。
临床应用与阅片要点
- 可依据融合T2WI、cT1WI和ADC图的影像组学标签及MRI报告的瘤周水肿,术前评估IDC患者LVI风险。
- 列线图可将患者分为高危和低危组,两组DFS存在显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop a multiparametric MRI-based radiomics nomogram for predicting lymphovascular invasion (LVI) status and clinical outcomes in patients with breast invasive ductal carcinoma (IDC).
METHODS: A total of 160 patients with pathologically confirmed breast IDC (training cohort: n = 112; validation cohort: n = 48) who underwent preoperative breast MRI were included. Imaging features were extracted from T2-weighted imaging (T2WI), apparent diffusion coefficient (ADC) maps, and contrast-enhanced T1-weighted imaging (cT1WI) sequences. A four-step procedure was applied for feature selection and radiomics signature building. Univariate and multivariate logistic regression analyses were conducted to identify the features associated with LVI, which were then incorporated into the radiomics nomogram. The performance of the nomogram was evaluated by its discrimination, calibration, and clinical usefulness. Kaplan-Meier survival curves based on the two radiomics models were used to estimate disease-free survival (DFS).
RESULTS: The fusion radiomics signature of the T2WI, cT1WI, and ADC maps achieved a better predictive efficacy for LVI than either of them alone. The proposed radiomics nomogram, incorporating the fusion radiomics signature and MRI-reported peritumoral edema, showed satisfactory capabilities of calibration and discrimination in both training and validation datasets, with AUCs of 0.919 (95% CI: 0.871-0.967) and 0.863 (95% CI: 0.726-0.999), respectively. The radiomics signature and nomogram-defined high-risk groups had a shorter DFS than those in the low-risk groups (both p < 0.05). Higher Rad-scores were independently associated with a worse DFS in the whole cohort (p < 0.05).
CONCLUSIONS: The proposed nomogram, incorporating multiparametric MRI-based radiomics signature and MRI-reported peritumoral edema, achieved a satisfactory preoperative prediction of LVI and clinical outcomes in IDC patients.
KEY POINTS: • The fusion radiomics signature of the T2WI, cT1WI, and ADC maps achieved a better predictive efficacy for LVI than either of them alone. • The proposed nomogram achieved a favorable prediction of LVI in IDC patients with AUCs of 0.919 and 0.863 in the training and validation datasets, respectively. • The radiomics model could classify patients into high- and low-risk groups with significant differences in DFS.
引用
- Zhang, Wang, Ren, et al. Multiparametric MRI-based radiomics nomogram for preoperative prediction of lymphovascular invasion and clinical outcomes in patients with breast invasive ductal carcinoma. Eur Radiol. 2022. PMID: 35050415. doi:10.1007/s00330-021-08504-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。